Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic IV Paracetamol in Extremely Premature Infants

NCT07067177 is registered in ClinicalTrials.gov with Al-Quds University as lead sponsor.

NCT NCT07067177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07067177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic IV Paracetamol in Extremely Premature Infants
Lead sponsor
Al-Quds University
Phase
Phase 2/3
Overall status
Completed
Start date
January 1, 2025
Completion date
November 1, 2025
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus (pda), patent ductus arteriosus after premature birth, patent ductus arteriosus in premature infants, patent ductus arteriosus in preterm infants